In spite of the challenging climate to raise capital, a North Carolina biotech company raised $42.5 million for its kidney-focused cancer drug.
Related Posts
-
Ole Miss hosting “Women and Entrepreneurship Week”
Nov 05 2017
-
WTBI winner Songboarding.com produces video on coronavirus safety measures
Mar 16 2020
-
More than half of $3 billion invested in VR and AR in 2017 went to just four start-ups
Jan 08 2018
-
EC’s McWhorter holds town hall meeting to get feedback
May 25 2015
-
BIP Capital releases “State of Start-ups in the Southeast” report
Oct 10 2018
-
City of Atlanta launches Students2Startups initiative
Apr 08 2018
Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.